Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer
University of Alabama at Birmingham
University of Alabama at Birmingham
Institut Curie
Emory University
Ohio State University Comprehensive Cancer Center
Stanford University
Institut Claudius Regaud
Baylor Research Institute
H. Lee Moffitt Cancer Center and Research Institute
The Methodist Hospital Research Institute